July 11, 2014 9:23 PM ET

Healthcare Equipment and Supplies

Company Overview of EMBOL-X, Inc.

Company Overview

As of April 16, 2003, EMBOL-X, Inc., Inc. was acquired by Edwards Lifesciences Corporation. EMBOL-X, Inc. develops and markets medical devices used in coronary artery bypass graft surgery. The company is focused on the development of proprietary medical devices to manage emboli and prevent stroke, neurological damage and other complications caused by embolic debris. EMBOL-X, Inc. was founded by Dr. Denise Barbut, M.D. and Dr. Jonathan Root, M.D. in February 1995 and is based in Mountain View, California.

645 Clyde Avenue

Mountain View, CA 94043-2208

United States

Founded in 1995

Phone:

650-390-0280

Fax:

650-390-0282

Key Executives for EMBOL-X, Inc.

EMBOL-X, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Invacare Continuing Care, Inc. United States
Cannuflow, Incorporated United States
Mayer-Johnson LLC United States
Solutions BioMed LLC United States
Berkley Medical Resources, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EMBOL-X, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.